A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response

Angew Chem Int Ed Engl. 2005 Nov 25;44(46):7630-5. doi: 10.1002/anie.200501594.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Formation / immunology*
  • Antibody Specificity
  • Antigens, Neoplasm / chemistry*
  • Antigens, Neoplasm / immunology
  • Cancer Vaccines / chemical synthesis
  • Cancer Vaccines / chemistry*
  • Cancer Vaccines / immunology
  • Carbohydrate Conformation
  • Carbohydrate Sequence
  • Epitopes, T-Lymphocyte / chemistry
  • Epitopes, T-Lymphocyte / immunology*
  • Glycopeptides / chemistry*
  • Glycopeptides / immunology
  • Models, Immunological
  • Molecular Sequence Data
  • Mucin-1 / chemistry
  • Mucin-1 / immunology
  • Stereoisomerism
  • Vaccines, Synthetic / chemistry*
  • Vaccines, Synthetic / immunology

Substances

  • Antigens, Neoplasm
  • Cancer Vaccines
  • Epitopes, T-Lymphocyte
  • Glycopeptides
  • Mucin-1
  • Vaccines, Synthetic